Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carrasco, E."'
Autor:
Martin, M, Zielinski, C, Ruiz-Borrego, M, Carrasco, E, Ciruelos, E, Munoz, M, Bermejo, B, Margeli, M, Turner, N, Casas, M, Anton, A, Csoszi, T, Corsaro, M, Murillo, L, Morales, S, Alba, E, Bartlett, CH, Koehler, M, Guerrero, A, Kahan, Z, Gil-Gil, M
Publikováno v:
Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6fe1f6e6553e13d596085a8e2b16ac7d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4318
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4318
Autor:
Martin, M., Loibl, S., von Minckwitz, G., Morales, S., Crespo, C., Anton, A., Guerrero, A., Aktas, B., Schoenegg, W., Garcia-Saenz, J. A., Gil, M., Ramos, M., Carrasco, E., Liedtke, C., Wachsmann, G., Mehta, K., De la Haba, J. R., Muñoz, M.
Publikováno v:
Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2173-2174. 2p.
Autor:
Martin, M., Brase, J. C., Ruiz-Borrego, M., Krappmann, K., Munarriz, B., Fisch, K., Ruiz, A., Weber, K. E., Crespo, C., Petry, C., Rodriguez, C. A., Kronenwett, R., Calvo, L., Alba, E., Carrasco, E., Casas, M., Caballero, R., Rodriguez-Lescure, A.
Publikováno v:
Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p603-604. 2p.
Autor:
Saura C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ortiz C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Matito J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Arenas EJ; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Suñol A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Martín Á; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Córdoba O; Servicio Obstetricia y Ginecología, Hospital Universitari Son Espases (HUSE), Palma, Spain.; Institut de Investigació de les Illes Balears (IdISBa), Palma, Spain.; Universitat de les Illes Balears (UIB), Palma, Spain., Martínez-Sabadell A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., García-Ruiz I; Obstetrics Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Miranda I; Radiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Morales-Comas C; Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Carrasco E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Peg V; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Pathology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain., Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Bayó-Puxan N; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Gonzalez-Medina A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Miquel JM; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Gómez-Rey M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Arévalo S; Obstetrics Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Espinosa-Bravo M; Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Arribas J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Barcelona, VIC, Spain.; IOB Institute of Oncology, Quiron Group, Barcelona, Spain., Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain., Sansó M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus. Barcelona, Spain.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Oct 05; Vol. 13 (10), pp. 2180-2191.
Autor:
Patel VL; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Busch EL; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Friebel TM; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Dana-Farber Cancer Institute. Boston, Massachusetts., Cronin A; Dana-Farber Cancer Institute. Boston, Massachusetts., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom., Agata S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Agnarsson BA; Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.; School of Medicine, University of Iceland, Reykjavik, Iceland., Ahmed M; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom., Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Alducci E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Arason A; Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Artioli G; ULSS 3 Serenissima, U.O.C. Oncologia ed Ematologia Oncologica, Mirano, Venice, Italy., Arver B; Department of Oncology, Karolinska Institutet, Stockholm, Sweden., Auber B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Balmaña J; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain., Barkardottir RB; Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Barroso A; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Belotti M; Service de Génétique, Institut Curie, Paris, France., Benitez J; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Bertelsen B; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands., Bodrogi I; Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary., Bonadona V; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France., Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bondavalli D; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Boonen SE; Clinical Genetic Unit, Department of Paediatrics, Zealand University Hospital, Roskilde, Denmark., Borde J; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Borg A; Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden., Bradbury AR; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Brady A; North West Thames Regional Genetics Service, Kennedy Galton Centre, The North West London Hospitals NHS Trust, Middlesex, United Kingdom., Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Brunet J; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain., Buecher B; Service de Génétique, Institut Curie, Paris, France., Buys SS; Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah., Cabezas-Camarero S; Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Caldés T; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Caliebe A; Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Caligo MA; Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy., Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Campbell IG; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Carnevali I; UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy., Carrasco E; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain., Chan TL; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong., Chu ATW; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York., Claes KBM; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Collaborators GS; Service de Génétique, Institut Curie, Paris, France., Collaborators E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom., Cortesi L; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Damante G; Department of Medical and Biological Sciences, University of Udine, Udine, Italy., Darder E; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain., Davidson R; Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom., de la Hoya M; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Puppa LD; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Díez O; Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Barcelona, Spain., Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Ditsch N; Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany., Domchek SM; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Donaldson A; Clinical Genetics Department, St Michael's Hospital, Bristol, United Kingdom., Dworniczak B; Institute of Human Genetics, University of Münster, Münster, Germany., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Eccles DM; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Eeles RA; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Ehrencrona H; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden., Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany., Evans DG; Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Science Centre, Manchester, United Kingdom., Faivre L; Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France., Faust U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Feliubadaló L; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Fostira F; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Fountzilas G; Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., García-Barberán V; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Garre P; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Gauthier-Villars M; Service de Génétique, Institut Curie, Paris, France., Géczi L; Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary., Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark., Gesta P; Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France., Giannini G; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada., Godwin AK; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Gutierrez-Barrera AM; Department of Breast Medical Oncology and Clinical Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas., Hahnen E; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hauke J; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Herold N; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Hogervorst FBL; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Honisch E; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois.; The University of Chicago Pritzker School of Medicine, Chicago, Illinois., Investigators K; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Investigators H; The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating center: The Netherlands Cancer Institute, Amsterdam, the Netherlands., Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Jager A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., James P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Janavicius R; Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania., Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Jensen TD; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Johannsson OT; Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland., John EM; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Joseph V; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York., Kang E; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea., Kast K; Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany., Kiiski JI; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea., Kim Z; Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea., Ko KP; Department of Preventive Medicine, Gacheon University College of Medicine, Incheon, Republic of Korea., Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Krogh L; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong., Larsen M; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Lasset C; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France., Lautrup C; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark., Lazaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Lee J; Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea., Lee JW; Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea., Lee MH; Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea., Lemke J; Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany., Lesueur F; Service de Génétique, Institut Curie, Paris, France.; Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., Liljegren A; Department of Oncology, Karolinska Institutet, Stockholm, Sweden., Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Llovet P; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Lopez-Fernández A; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain., Lopez-Perolio I; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Lorca V; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Loud JT; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Ma ESK; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong., Mai PL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Mari V; Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France., Martin L; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Matricardi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Mebirouk N; Service de Génétique, Institut Curie, Paris, France.; Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., Medici V; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Meijers-Heijboer HEJ; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands., Meindl A; Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany., Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Miller C; Department of Clinical Genetics, Alder Hey Hospital, Liverpool, United Kingdom., Gomes DM; Service de Biologie de la Reproduction, Cytogénétique et Génétique Médicale, CHI Poissy - Saint Germain, Poissy, France., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Mooij TM; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Moserle L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Mouret-Fourme E; Service de Génétique, Institut Curie, Paris, France., Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada., Nathanson KL; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Navratilova M; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Niederacher D; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Nielsen FCC; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Nikitina-Zake L; Latvian Biomedical Research and Study Centre, Riga, Latvia., Offit K; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois., Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, United Kingdom., Osorio A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Ott CE; Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy., Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pedersen IS; Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark., Peissel B; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Peixoto A; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal., Pérez-Segura P; Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy., Petersen AH; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Porteous ME; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom., Pujana MA; Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, in Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy., Ramser J; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Rashid MU; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan., Rhiem K; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Rizzolo P; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Robson ME; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York., Rookus MA; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rossing CM; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Santos C; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal., Saule C; Service de Génétique, Institut Curie, Paris, France., Scarpitta R; Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy., Schmutzler RK; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Schuster H; Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Paul Strauss, Strasbourg, France., Senter L; Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio., Seynaeve CM; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Shah PD; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Sharma P; Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas., Shin VY; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong., Silvestri V; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval, Research Centre, Québec City, Québec, Canada., Singer CF; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Skytte AB; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Snape K; Medical Genetics Unit, St George's, University of London, London, United Kingdom., Solano AR; INBIOMED, Faculty of Medicine/CONICET and CEMIC, Department of Clinical Chemistry, Medical Direction, University of Buenos Aires, Buenos Aires, Argentina., Soucy P; Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas., Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Steele L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Descartes, Paris, France., Stradella A; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Sunde L; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Tan YY; Department of OB/GYN, Medical University of Vienna, Vienna, Austria., Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal., Teo SH; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Quebec, Canada.; Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom., Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio., Tommasi S; Istituto Nazionale Tumori 'Giovanni Paolo II, Bari, Italy., Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia., Toss A; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., van der Baan FH; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Kolk LE; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Luijt RB; Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands., van Hest LP; Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Varesco L; Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy., Varon-Mateeva R; Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Viel A; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Vierstraete J; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Villa R; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy., von Wachenfeldt A; Department of Oncology, Karolinska Institutet, Stockholm, Sweden., Wagner P; Department of Women's Health, Tubingen University Hospital, Tubingen, Germany., Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Wappenschmidt B; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Weitzel JN; Clinical Cancer Genetics, City of Hope, Duarte, California., Wieme G; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Yadav S; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Yannoukakos D; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Yoon SY; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia., Zanzottera C; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Zorn KK; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., D'Amico AV; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Freedman ML; Dana-Farber Cancer Institute. Boston, Massachusetts., Pomerantz MM; Dana-Farber Cancer Institute. Boston, Massachusetts., Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Ottini L; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Nielsen HR; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Rebbeck TR; Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Timothy_Rebbeck@dfci.harvard.edu.; Dana-Farber Cancer Institute. Boston, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2020 Feb 01; Vol. 80 (3), pp. 624-638. Date of Electronic Publication: 2019 Nov 13.
Autor:
Cejalvo JM; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain., Martínez de Dueñas E; Hospital Provincial de Castellón, Castellón, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Galván P; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., García-Recio S; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Burgués Gasión O; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Pathology, Hospital Clínico Universitario de Valencia, Spain., Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Antolín S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Martinello R; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Blancas I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain., Adamo B; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Guerrero-Zotano Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Muñoz M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Nucíforo P; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Pérez RM; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Quirón de Madrid, Madrid, Spain., Chacón López-Muniz JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Virgen de la Salud, Toledo, Spain., Caballero R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Peg V; Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rojo F; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Perou CM; University of North Carolina, Chapel Hill, North Carolina., Cortés J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Ramón y Cajal University Hospital, Madrid, Spain., Adamo V; University of Messina, Messina, Italy., Albanell J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Gomis RR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; ICREA, Barcelona, Spain., Lluch A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Cancer research [Cancer Res] 2017 May 01; Vol. 77 (9), pp. 2213-2221. Date of Electronic Publication: 2017 Mar 01.